Claire Noell, MD
Dermatology · Boston, MANPI 1457779589
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,754 of the $4,907 with a category attached, or 76.5%. 29 manufacturers reported payments, led by Pfizer at 24.2% of the total. Reporting peaked in 2023 at $1,965 and has fallen 53.3% since, to $918 in 2025.
Across 142 payments — averaging $34.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- AbbVie$696
- Johnson & Johnson$433
- Galderma Laboratories, L.p.$358
- Regeneron Healthcare Solutions, Inc.$267
- E.r. Squibb & Sons, L.L.C.$260
- plus $2K from 23 others
Across 6 payments — averaging $4165.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Avita Medical Americas, LLC$25K
What the payments were for
- Consulting fees$1754%
- Travel & lodging$68914%
- Food & beverage$3,75476%
- Education$2906%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 9 | $1,189 |
| AbbVie(2 entities) | 26 | $696 |
| Johnson & Johnson | 12 | $433 |
| Galderma Laboratories, L.p. | 14 | $358 |
| Regeneron Healthcare Solutions, Inc. | 9 | $267 |
| E.r. Squibb & Sons, L.L.C. | 11 | $260 |
| Sun Pharmaceutical Industries Inc. | 5 | $183 |
| Incyte Corporation | 9 | $177 |
| Avita Medical Americas, LLC | 1 | $175 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $130 |
| Sanofi | 6 | $106 |
| Organon | 5 | $102 |
| Dermavant Sciences, Inc. | 4 | $93 |
| Lilly USA, LLC | 3 | $93 |
| VYNE Pharmaceuticals Inc. | 2 | $69 |
| Endo Pharmaceuticals Inc. | 1 | $68 |
| Arcutis Biotherapeutics, Inc. | 3 | $57 |
| LEO Pharma Inc. | 2 | $56 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $55 |
| Elekta, Inc. | 1 | $53 |
| Biofrontera Inc. | 3 | $51 |
| Revance Therapeutics, Inc. | 1 | $44 |
| Almirall LLC | 3 | $44 |
| UCB, Inc. | 2 | $32 |
| Botanix SB Inc | 1 | $25 |
| EPI Health, LLC | 1 | $25 |
| Novartis | 1 | $23 |
| Boston Scientific | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,907 in reported general payments places this provider in the 70th percentile of 552 dermatology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 27 | $1,374 |
| Tacrolimus | 11 | $1,062 |
| Tretinoin | 17 | $776 |
| Metronidazole | 15 | $563 |
| Clindamycin Phosphate | 14 | $538 |
| Doxycycline Hyclate | 16 | $400 |
| Ketoconazole | 21 | $292 |
| Triamcinolone Acetonide | 25 | $218 |
| Finasteride | 13 | $215 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Boston
- Alexandra KimballBoston$680K
- Arash MostaghimiBoston$591K
- Brian HiblerBoston$498K
- Maryanne SennaBoston$430K
- Ruth Ann VleugelsBoston$368K
- Gabriela CobosBoston$343K
- Martina PorterBoston$220K
- Mathew AvramBoston$209K
- Emmy GraberBoston$159K
- Neelam VashiBoston$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.